eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 22/03/2012
PIL ORENCIA 250 mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 12/07/2010 and displayed until 22/03/2012
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to side-effects
Updated on 02/02/2010 and displayed until 12/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 03/07/2009 and displayed until 02/02/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 03/07/2007 and displayed until 03/07/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 08/06/2007 and displayed until 03/07/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   abatacept